UAE becomes second country to approve gene therapy itvisma for spinal muscular atrophy | World News - The Times of India
The UAE approved Itvisma gene therapy for SMA, improving motor function and reducing long-term treatments/Image: WAM The UAE has taken a major step in healthcare innovation by approving Itvisma (onasemnogene abeparvovec), a gene therapy for spinal muscular atrophy (SMA) in adults and children aged two years and above. This makes the country only the second in the world to authorize the…
View On WordPress














